Metformin Increases Sensitivity of Melanoma Cells to Cisplatin by Blocking Exosomal-Mediated miR-34a Secretion
Authors:
Open Access
- 29 November 2021
- journal article
- research article
- Published by Wiley in Journal of Oncology
- Vol. 2021, 1-7
Abstract
Melanoma, also known as malignant melanoma, is a type of cancer derived from the pigment-containing cells known as melanocytes. Cisplatin (CDDP) is widely used in the treatment of different types of tumors with high response rates, but it generally has low efficiency in melanoma. This study aimed to investigate whether metformin could sensitize the melanoma cell line A375 to cisplatin. Our results for the first time indicated that CDDP increased the miR-34a secretion by exosomes in melanoma A375 cells, which was, at least partially, related to the cisplatin resistance of melanoma cells. Moreover, metformin significantly sensitized A375 cells to cisplatin. Mechanistically, metformin significantly blocked the exosome-mediated miR-34a secretion induced by cisplatin. Our study not only reveals a novel mechanism that exosomal secretion of miR-34a is involved in the cisplatin resistance of melanoma cells but also provides a promising therapeutic strategy by synergistic addition of metformin.Keywords
Funding Information
- Southwest Hospital (SWH2018QNKJ-26)
This publication has 41 references indexed in Scilit:
- Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapyMolecular Cancer, 2014
- Low and high linear energy transfer radiation sensitization of HCC cells by metforminJournal of Radiation Research, 2013
- Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 DiabetesDiabetes Care, 2011
- Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthaseEndocrine-Related Cancer, 2010
- miR-34a repression of SIRT1 regulates apoptosisProceedings of the National Academy of Sciences, 2008
- MicroRNA-34b and MicroRNA-34c Are Targets of p53 and Cooperate in Control of Cell Proliferation and Adhesion-Independent GrowthCancer Research, 2007
- p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor GenesCurrent Biology, 2007
- A microRNA component of the p53 tumour suppressor networkNature, 2007
- Transcriptional Activation of miR-34a Contributes to p53-Mediated ApoptosisMolecular Cell, 2007
- Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes ApoptosisMolecular Cell, 2007